Association of Bcr-Abl Tyrosine Kinase Inhibitors With Hepatitis B Virus Reactivation Requiring Antiviral Treatment in Taiwan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of Bcr-Abl Tyrosine Kinase Inhibitors With Hepatitis B Virus Reactivation Requiring Antiviral Treatment in Taiwan

Published:2021-04-06 Issue:4 Volume:4 Page:e214132
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Wang Ling-Yi¹²³,Chu Sung-Chao⁴,Lo Yin⁵,Yang Yen-Yun⁶,Chan K. Arnold⁶⁷

Affiliation:

1. Epidemiology and Biostatistics Consulting Center, Department of Medical Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan

2. Department of Pharmacology, School of Medicine, College of Medicine, Tzu Chi University, Hualien, Taiwan

3. Department of Pharmacy, Buddhist Tzu Chi General Hospital, Hualien, Taiwan

4. Department of Hematology and Oncology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan

5. Department of Pharmacy, National Taiwan University Hospital

6. Health Data Research Center, National Taiwan University

7. Department of Medical Research, National Taiwan University Hospital

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2778180/wang_2021_oi_210152_1617035357.60757.pdf

Reference38 articles.

1. Drug-induced liver injury—types and phenotypes.;Hoofnagle;N Engl J Med,2019

2. Towards the eradication of hepatitis B in Taiwan.;Wait;Kaohsiung J Med Sci,2012

3. Systemic corticosteroid and reactivation of chronic hepatitis B.;Lai;Respirology,2010

4. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.;Reddy;Gastroenterology,2015

5. Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions.;Loomba;Gastroenterology,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors;World Journal of Gastroenterology;2024-06-28

2. Sex‐specific incidence of hepatitis B virus flares among Bcr‐Abl tyrosine kinase inhibitor users in Taiwan;Pharmacoepidemiology and Drug Safety;2023-07-18

3. Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment;Journal of Clinical Medicine;2022-12-28

4. Hepatitis B Virus Reactivation Associated With Therapeutic Interventions;Frontiers in Medicine;2022-01-14

5. Pharmacology and pharmacovigilance of protein kinase inhibitors;Therapies;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3